15 European Countries Approve Use Of Relenza® In Prevention Of Influenza A And B

... GlaxoSmithKline (GSK) today announces that it has received approval from European Regulators in 15 EU countries for use of its anti-viral Relenza ® (zanamivir for inhalation) in the prevention (prophylaxis) of influenza A and B in adults and children 5 years of age and above.Approval was also received today for the treatment of influenza in children 5 years of age and above. [click link for full article] ...